Newbridge Financial Services Group Inc. Invests $111,000 in CVS Health Co. (NYSE:CVS)

Newbridge Financial Services Group Inc. acquired a new position in shares of CVS Health Co. (NYSE:CVS) in the 4th quarter, HoldingsChannel.com reports. The fund acquired 2,468 shares of the pharmacy operator’s stock, valued at approximately $111,000.

Several other large investors also recently bought and sold shares of the company. MidAtlantic Capital Management Inc. purchased a new stake in shares of CVS Health in the 3rd quarter worth about $25,000. Ridgewood Investments LLC raised its position in CVS Health by 255.7% during the fourth quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock worth $28,000 after acquiring an additional 450 shares during the last quarter. Livelsberger Financial Advisory acquired a new stake in shares of CVS Health in the third quarter valued at approximately $31,000. Legacy Investment Solutions LLC purchased a new position in shares of CVS Health during the 3rd quarter worth approximately $31,000. Finally, Reston Wealth Management LLC purchased a new stake in CVS Health in the 3rd quarter valued at approximately $32,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Stock Performance

NYSE CVS opened at $54.24 on Tuesday. The business’s 50-day simple moving average is $50.79 and its 200-day simple moving average is $55.98. The firm has a market capitalization of $68.26 billion, a P/E ratio of 13.77, a P/E/G ratio of 0.60 and a beta of 0.61. CVS Health Co. has a 1-year low of $43.56 and a 1-year high of $80.75. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd were given a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 4.90%. The ex-dividend date was Thursday, January 23rd. CVS Health’s payout ratio is currently 67.51%.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on CVS shares. UBS Group boosted their price target on CVS Health from $60.00 to $62.00 and gave the stock a “neutral” rating in a report on Thursday, November 7th. StockNews.com lowered shares of CVS Health from a “hold” rating to a “sell” rating in a report on Thursday, November 14th. Deutsche Bank Aktiengesellschaft upgraded shares of CVS Health from a “hold” rating to a “buy” rating and set a $66.00 price target for the company in a report on Tuesday, December 3rd. Mizuho decreased their target price on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating on the stock in a research report on Thursday, October 24th. Finally, Truist Financial cut their price target on CVS Health from $67.00 to $60.00 and set a “buy” rating for the company in a report on Monday, January 6th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and fourteen have given a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $68.12.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.